Definium LSD drug goes 3 for 3 with another pivotal trial win in anxiety
Definium has reported its third consecutive Phase 3 trial win for its LSD-based therapy in anxiety disorders.
Definium Therapeutics
Private
Biopharmaceutical company. See latest news.